Skip to main content

Table 1 The top 11 loci for Gemcitabine (A) and the top 27 loci for AraC (B) that were associated with drug response-IC50 values

From: Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines

 Top SNP rsID

 Lowest R

 Lowest P

 Nearby gene

 Chr

 Position

 MAF

Region

Number of SNPs in each locus

(A) Gemcitabine

rs10513968

−0.382

1.04E-06

DOK6

18

65434121

0.445

Intron

9

rs7719624

−0.370

4.22E-06

TGFBI

5

135405465

0.448

Intron

28

rs2274870

0.362

4.33E-06

NIPSNAP3A

9

106555035

0.371

Coding

7

rs316838

−0.345

1.21E-05

PLD5*

1

240387283

0.093

Intron

12

rs2638094

−0.339

1.72E-05

ZNF215*

11

6938064

0.679

Flanking_3UTR

5

rs2290344

0.339

1.75E-05

PIGB

15

53407088

0.253

Coding

9

rs3129890

0.332

2.67E-05

HLA-DRA*

6

32522251

0.340

Flanking_3UTR

23

rs2928445

−0.331

2.76E-05

IPMK

10

58816782

0.267

Flanking_3UTR

23

rs4392391

−0.318

5.78E-05

C3orf23

3

44247970

0.419

Downstream

15

rs12522395

0.318

6.58E-05

MASS1*

5

90246274

0.215

Intron

4

rs13171512

−0.313

7.857E-05

PIK3R1

5

68000787

0.462

Flanking_3UTR

4

(B) AraC

rs10495285

0.393

4.13E-07

KIAA0133 (URB2)

1

227871618

0.171

Downstream

2

rs1450679

0.389

5.20E-07

SMC2L1

9

106066633

0.098

Flanking_3UTR

8

rs6128386

0.375

1.38E-06

LOC149773

20

56626955

0.466

Upstream

4

rs2172820

−0.373

1.63E-06

TUSC3

8

15370039

0.256

Flanking_5UTR

13

rs2857891

−0.372

1.75E-06

ZNF215*

11

6919533

0.101

Intron

6

rs9512755

−0.361

3.67E-06

LNX2

13

27056229

0.055

Flanking_5UTR

4

rs888468

−0.356

5.08E-06

FGF6

12

4403640

0.184

Flanking_3UTR

5

rs2653165

−0.347

9.28E-06

PLD5*

1

240432905

0.207

Intron

7

rs11215416

−0.346

9.57E-06

IGSF4

11

114582537

0.147

Intron

7

rs10060641

0.335

1.90E-05

MASS1*

5

90249006

0.216

Intron

7

rs5989586

0.336

1.94E-05

HDHD1A

23

6757306

0.457

Flanking_3UTR

8

rs216465

−0.330

2.76E-05

GOSR1

17

25880801

0.494

Flanking_3UTR

12

rs856548

−0.326

3.29E-05

TNS3

7

46730993

0.296

Flanking_3UTR

8

rs6689258

0.325

3.40E-05

GPR137B

1

234362702

0.267

Flanking_5UTR

2

rs3794794

−0.325

3.61E-05

CPD

17

25744867

0.477

Intron

10

rs7192

0.322

4.10E-05

HLA-DRA*

6

32519624

0.371

Coding

11

rs4572738

0.322

4.45E-05

CAST1

3

55799452

0.321

Intron

8

rs1433446

0.319

5.05E-05

TMEM83

15

85351874

0.109

Flanking_5UTR

5

rs300962

0.320

5.47E-05

LOC51334

5

119909842

0.269

Intron

15

rs6441911

0.315

6.20E-05

RIS1

3

45322523

0.055

Flanking_5UTR

6

rs1159388

0.314

6.61E-05

DCAMKL1

13

35544706

0.172

Intron

11

rs718979

0.313

6.82E-05

UBE3A

15

23325370

0.394

Flanking_5UTR

6

rs1955412

0.309

8.74E-05

FLRT2

14

85082547

0.21

Intron

11

  1. Each locus contained at least 2 SNPs within 50 kb with P values <10-4. R values represent correlation coefficients for the association. Number of SNPs indicates the number of significantly associated SNPs in the locus. rsID indicates the most significant SNP associated with drug cytotoxicity in the locus. * = common to both gemcitabine and AraC.